Screening and MelaFind Sam Karnes BME 281黑色素瘤筛查和melafind山姆卡恩斯BME ppt课件.pptVIP

下载本文档

2
0
约3.52千字
约 10页
2018-07-31 发布于贵州
举报
版权申诉

Screening and MelaFind Sam Karnes BME 281黑色素瘤筛查和melafind山姆卡恩斯BME ppt课件.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Screening and MelaFind Sam Karnes BME 281黑色素瘤筛查和melafind山姆卡恩斯BME ppt课件

临床医学于波心房选择性钠通道阻滞剂在房颤中的应用颅内非肿瘤性病变的影像学表现基础医学慢性鼻窦炎鼻息肉围手术期综合治疗的临床指引泌尿生殖道感染衣原体检测和支原体培养及药敏结果分析临床医学于波心房选择性钠通道阻滞剂在房颤中的应用颅内非肿瘤性病变的影像学表现基础医学慢性鼻窦炎鼻息肉围手术期综合治疗的临床指引泌尿生殖道感染衣原体检测和支原体培养及药敏结果分析临床医学于波心房选择性钠通道阻滞剂在房颤中的应用颅内非肿瘤性病变的影像学表现基础医学慢性鼻窦炎鼻息肉围手术期综合治疗的临床指引泌尿生殖道感染衣原体检测和支原体培养及药敏结果分析 Melanoma Screening and MelaFind?Sam KarnesBME 281 Melanoma UV ray exposure damages DNA of skin cells Cancer cells Grow without control Invade surrounding tissues (metastasize) Tumors Cancerous vs. Benign Most Deadly Form of Skin Cancer but treatable if identified early Mela Sciences Inc Became a part of Electro-Optical Sciences 1989 RD projects for the Department of Defense remote sensing and image analysis Mid 1990s Worked with NYU Applied signal processing techniques towards medical applications Developed DIFOTI, SkinSurf, SLIM, and MelaFind MelaFind? Provides dermatologist more information when considering a biopsy Composed of Illuminator Blue to near infrared Lens System Photon Sensor Identifies cancerous skin lesions Algorithms that automatically analyze results Results 1632 lesions for analysis 175 lesions were identified as positive Overall the device showed that 98.3% were melanoma (172/175) Device discovered 10.8% of the negative class lesions Dermatologists in the study only found 5.6%. Avoidable biopsies reduced by 90% Advantages Reduces skin cancer fatalities Reduces biopsy procedures Reduced costs No adverse side effects Approved for pre-market use in U.S. and approved for sale in European Union Results are extremely accurate Disadvantages Not covered by insurance Isopropyl alcohol used in lesion preparation can cause skin irritation Not yet available to the general population Costs MelaFind? costs $7,500 Includes placement and training Cost per patient $50 per lesion or ~$150 for multiple lesions Cost of biopsy Between $150 and $1000 Future of MelaFind? Could be publically available Reduce size and price Help patients with medical history of skin cancer Insuranc